Search results for "Complement C3"

showing 10 items of 69 documents

Quantitative contributions of IgG, IgM and C3 to erythrophagocytosis and rosette formation by peritoneal macrophages, and anti-opsonin activity of de…

1976

In vitro phagocytosis by guinea pig peritoneal macrophages of immune complexes (EA) was shown to be dependent on IgG antibody in a dose-dependent fashion. C3b enhanced phagocytosis of EA at limited IgG antibody concentrations only. When IgM antibody was used for sensitization of sheep red blood cells (SRBC), phagocytosis and rosette formation did not occur in the absence of bound C3. The polyanion, dextran sulfate 500 (DS), was shown to depress both rosette formation and phagocytosis of EAIgG, C1423 and EAIgMC1423, as well as immune adherence of human group 0 erythrocytes and hemolytic activity of C3. This effect of DS was seen only when it was actually present in the incubation medium.

ErythrocytesPhagocytosisImmunologyGuinea PigsDose-Response Relationship ImmunologicHemolysisMicrobiologyGuinea pigImmune systemPhagocytosismedicineCell AdhesionImmunology and AllergyAnimalsIncubationSensitizationbiologyMacrophagesImmune adherenceDextransComplement C3Complement System ProteinsOpsonin ProteinsIn vitroImmune Adherence Reactionmedicine.anatomical_structureImmunoglobulin MImmunoglobulin Gbiology.proteinAntibodyEuropean journal of immunology
researchProduct

Role of β1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells

1981

Coating of EAC14oxy23b with highly purified human serum beta 1H globulin (beta 1H) led to acceleration of rosette formation with human peripheral blood lymphocytes (PBL), tonsil lymphocytes, B lymphoblastoid (Raji) cells, granulocytes and monocytes. This reaction was discernible from C3bi-dependent rosette formation. Enhancement of rosette formation of C3b cells by beta 1H was most effective at limiting amounts of C3 per EAC14oxy23b. The beta 1H effect was not due to trace contamination with C3b inactivator. beta 1H-dependent rosette formation with the various lymphoid and phagocytic cells could be suppressed by the F(ab')2 fragment of anti-beta 1H suggesting beta 1H-mediated binding of bet…

ErythrocytesRosette FormationGlobulinGuinea PigsImmunologyTurn (biochemistry)Immunoglobulin Fab FragmentsComplement C3b Inactivator ProteinsmedicineAnimalsHumansImmunology and AllergyLymphocytesBeta (finance)ReceptorPhagocytesBinding SitesSheepbiologyGoatsLymphoblastMolecular biologyReceptors ComplementRaji cellmedicine.anatomical_structureRosette formationComplement Factor HTonsilComplement C3bImmunologybiology.proteinEuropean Journal of Immunology
researchProduct

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

2015

Complement C1q is the activator of the classical pathway. However, it is now recognized that C1q can exert functions unrelated to complement activation. Here we show that C1q, but not C4, is expressed in the stroma and vascular endothelium of several human malignant tumours. Compared with wild-type (WT) or C3- or C5-deficient mice, C1q-deficient (C1qa−/−) mice bearing a syngeneic B16 melanoma exhibit a slower tumour growth and prolonged survival. This effect is not attributable to differences in the tumour-infiltrating immune cells. Tumours developing in WT mice display early deposition of C1q, higher vascular density and an increase in the number of lung metastases compared with C1qa−/− mi…

Genetics and Molecular Biology (all)0301 basic medicinePROTEINGeneral Physics and AstronomyMELANOMAApoptosisInbred C57BLBiochemistryDISEASEAnimals; Apoptosis; Cell Line Tumor; Cell Movement; Cell Proliferation; Complement Activation; Complement C1q; Complement C3; Complement C5; Humans; Mice; Mice Inbred C57BL; Mice Knockout; Neoplasms; Biochemistry Genetics and Molecular Biology (all); Chemistry (all); Physics and Astronomy (all)Micefluids and secretionsCell Movementimmune system diseasesNeoplasmsIMMUNE-RESPONSEskin and connective tissue diseasesComplement ActivationComplement C1qMice KnockoutComplement component 5TumorMultidisciplinaryQChemistry (all)Complement C5Complement C33. Good healthCell biologyMultidisciplinary SciencesDEFICIENCYmedicine.anatomical_structureScience & Technology - Other TopicsHumanKnockoutSciencechemical and pharmacologic phenomenaBiologyArticleGeneral Biochemistry Genetics and Molecular BiologyTROPHOBLAST INVASIONMECHANISMSCell LinePhysics and Astronomy (all)03 medical and health sciencesClassical complement pathwayImmune systemINFLAMMATIONCell Line TumormedicineAnimalsHumansCell ProliferationScience & TechnologyBiochemistry Genetics and Molecular Biology (all)AnimalCell growthEFFECTOR SYSTEMComplement C1qApoptosiGeneral ChemistryComplement systemMice Inbred C57BL030104 developmental biologyCancer cellNeoplasmBone marrowANTIBODY THERAPYNature Communications
researchProduct

Complement component C3: molecular basis of the C3*S025 variant and evidence for molecular heterogeneity of other variants.

1995

Complement component 3 (C3) is the central molecule of the complement system. It displays a number of polymorphic variants with, as yet, unclear functional consequences. We have investigated a number of rare C3 variants by PCR-SSCP (polymerase chain reaction-single strand conformation polymorphism) analysis and could identify the molecular basis of a C3*S025 variant. The decreased electrophoretic mobility of this protein is caused by the exchange of a neutral serine residue to an arginine residue (positively charged). This exchange is unlikely to have functional consequences as it maps to the C-terminus of the alpha-chain. C3 variants appear to have originated from various independent mutat…

GeneticsComplement component 3biologyBase SequenceGenetic heterogeneityMolecular Sequence DataComplement C3Molecular medicinePolymerase Chain Reactionlaw.inventionComplement systemSerineGenetic HeterogeneitylawGeneticsbiology.proteinHumansGeneGenetics (clinical)Polymerase chain reactionPolymerasePolymorphism Single-Stranded ConformationalHuman genetics
researchProduct

In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages

1976

Factor B of the alternative pathway of complement activation was shown to be synthesized and secreted by unstimulated mouse peritoneal macrophages. The activity of B in the culture supernatants from macrophage monolayers was detected by consumption of C3 in reaction mixtures containing supernatant and guinea pig factors C3, D and insoluble C3b. Using a monospecific antiserum, factor B in concentrated culture supernatants was shown by immunodiffusion and immunoelectrophoresis to be identical to factor B in mouse plasma and to form a characteristic complex with cobra venom factor in the presence of D. A steady rate of factor B secretion was observed for 4 days providing the medium was changed…

Guinea PigsImmunologyImmunoelectrophoresisCycloheximideBiologyComplement factor BMicechemistry.chemical_compoundmedicineAnimalsAscitic FluidImmunology and AllergyCycloheximideCells CulturedGlycoproteinsAntiserumProperdinmedicine.diagnostic_testMacrophagesComplement C3Complement System ProteinsMolecular biologyIn vitroComplement systemImmunodiffusionKineticschemistryBiochemistryAlternative complement pathwayEuropean Journal of Immunology
researchProduct

Combined homozygous factor H and heterozygous C2 deficiency in an Italian family

1988

Three of four children in a family have homozygous (less than 1% of normal) deficiency of factor H of the complement system and both parents, who are first cousins, are heterozygous for the same defect. The father and two of the H-deficient siblings also have a partial C2 deficiency. One of the children with combined deficiencies is affected by systemic lupus erythematosus with nephritis. No increased susceptibility to infections has been observed in the family. H deficiency is inherited in an autosomal codominant manner and is independently transmitted from C2 deficiency and HLA haplotypes. In the homozygous state it is associated with very low serum concentrations of B and C3, barely demo…

Heterozygotemedicine.medical_specialtyGenetic LinkageImmunologyHLA AntigensInternal medicineComplement C3b Inactivator ProteinsmedicineHumansLupus Erythematosus SystemicImmunology and AllergyChildImmunoelectrophoresisLupus erythematosusComplement component 2business.industryHomozygoteHeterozygote advantageComplement C2Complement deficiencymedicine.diseasePedigreeComplement systemEndocrinologyComplement Factor HFactor HComplement C3bImmunologyProperdinFemalebusinessNephritisComplement Factor BJournal of Clinical Immunology
researchProduct

Opsonizing activities of IgG, IgM antibodies and the C3b inactivator-cleaved third component of complement in macrophage phagocytosis

1976

Phagocytosis of SRBC by guinea-pig peritoneal macrophages is enhanced by opsonizing IgG antibody alone. IgM antibody requires the presence of bound C3. Treatment of C3b coated SRBC with purified C3b inactivator (yielding EAIgM C1423d) does not reduce attachment to, and phagocytosis by, peritoneal macrophages. This finding suggests the existence of a C3d receptor on peritoneal macrophages. EC43b intermediates which have been produced by removing IgM antibody by mercaptoethanol treatment and by subsequent removal of C1 and C2, are phagocytosed despite the absence of IgM antibody. Furthermore, treatment of EC43b with C3b inactivator does not change phagocytosis. Thus, IgM antibody does not app…

Igm antibodyReceptors DrugPhagocytosisGuinea PigsImmunologychemical and pharmacologic phenomenaStimulationToxicologyMicrobiologyMacrophage phagocytosisPhagocytosisOpsonin ProteinsC3b inactivatorAnimalsPharmacology (medical)ReceptorPharmacologybiologyChemistryMacrophagesCell MembraneComplement C3Complement System ProteinsOpsonin ProteinsImmunoglobulin MImmunoglobulin GImmunologybiology.proteinAntibodyAgents and Actions
researchProduct

Immunohistological differential diagnosis of inflammatory colonic diseases.

1984

Immunohistological investigations were carried out on human colonic tissue from, I healthy mucosa, 2 slightly inflamed mucosa, 3 mucosa with ulcerative colitis, 4 mucosa with Crohn's colitis, using antibodies against immunoglobulins and complement components. All our antibodies, including F(ab')2 fragments, demonstrated a progressive increase of labelled cells from healthy mucosa through slightly inflamed mucosa to mucosa with ulcerative colitis, in contrast to a complete absence of labelled cells in cases of Crohn's disease. The results are discussed with regard to their pathogenesis and their clinical significance for the differentiation of ulcerative colitis and Crohn's colitis.

Immunoglobulin Amedicine.medical_specialtyPathologyHistologyComplement Activating EnzymesGastroenterologyPathology and Forensic MedicinePathogenesisDiagnosis DifferentialCrohn DiseaseInternal medicinemedicineHumansColitisCrohn's diseasebiologybusiness.industryHistocytochemistryComplement C1qImmunochemistryComplement C4General MedicineComplement C3medicine.diseaseColitisUlcerative colitisdigestive system diseasesImmunoglobulin AImmunoglobulin MImmunoglobulin Mbiology.proteinImmunohistochemistryColitis UlcerativeAntibodybusinessGranulocytesHistopathology
researchProduct

Binding to complement factors and activation of the alternative pathway by Acanthamoeba.

2010

Acanthamoeba can cause severe ocular and cerebral diseases in healthy and immunocompromised individuals, respectively. Activation of complement appears to play an important role in host defence against infection. The exact mechanism, however, is still unclear. The aim of the present study was to investigate the effect of normal human serum (NHS) and normal mouse serum (NMS) on Acanthamoeba trophozoites, the binding of different complement factors to Acanthamoeba and the activation of the complement system. Moreover, we aimed to work out any possible differences between different strains of Acanthamoeba. A virulent T4 strain, a non-virulent T4 strain and a virulent T6 strain were included in…

ImmunologyComplement Pathway AlternativeVirulenceAcanthamoebaComplement factor IAntigen-Antibody ComplexImmunofluorescenceMannose-Binding LectinBacterial AdhesionMicrobiologyMiceSpecies Specificityparasitic diseasesmedicineImmunology and AllergyAnimalsHumansTrophozoitesIncubationEdetic AcidMice Knockoutmedicine.diagnostic_testbiologyVirulenceComplement C1qHematologyAmebiasisComplement C3biology.organism_classificationComplement C9Complement systemAcanthamoebaMice Inbred C57BLAlternative complement pathwayIntracellularImmunobiology
researchProduct

Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosoma…

1982

To quantitate the secretion of complement component C3 by guinea pig peritoneal macrophages an enzyme-linked immunosorbent assay was developed. C3 secretion was studied in resident, elicited and activated macrophages and compared with release of hemolytically active C2 and C4, as well as the lysosomal enzyme β-D-2-acetamido-2-deoxyglucosidase. Resident macrophages secreted about 6 ng C3/106 cells/h into culture supernatants over a period of 12 h. Corynebacterium parvum-activated cells were found to secrete 3 times that amount at nearly constant rates. There was a stepwise increase in secretion of functional C2 and C4 when comparing resident, elicited and activated macrophages; secretion was…

ImmunologyEnzyme releaseGuinea PigsCorynebacteriumEnzyme-Linked Immunosorbent AssayHemolysisGuinea pigAcetylglucosaminidaseImmunology and AllergyAnimalsHumansSecretionPropionibacterium acnesSerum Albuminchemistry.chemical_classificationbiologyMacrophagesComplement C4Complement C3Complement C2Macrophage Activationbiology.organism_classificationMolecular biologyKineticsEnzymechemistryCell culture supernatantLysosomesEuropean journal of immunology
researchProduct